Drug profile · INN
caffeine
PEYONA (PREVIOUSLY NYMUSA)
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
caffeine (PEYONA (PREVIOUSLY NYMUSA)) is an FDA-listed pharmaceutical active ingredient. Route of administration: rectal. Current US regulatory status: approved.
Key facts
INN caffeine
Brand PEYONA (PREVIOUSLY NYMUSA)
Route RECTAL
Formulation SUPPOSITORY
ATC code N06BC01
Frequently asked questions
What is caffeine?
caffeine (PEYONA (PREVIOUSLY NYMUSA)) is an FDA-listed pharmaceutical active ingredient. Route of administration: rectal. Current US regulatory status: approved.
What is the brand name for caffeine?
PEYONA (PREVIOUSLY NYMUSA) is a marketed brand name for caffeine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of caffeine?
caffeine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.